Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06768814 · ClinicalTrials.gov registry record · NA

Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

A NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Washington.

Recruiting
Registry status
NA
Development phase
40,000
Enrollment target
1
Study location

NCT06768814: Recruiting NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Washington.

NCT06768814 is a NA study of Opioid Use Disorder and Opioid Use that is actively recruiting participants, run by University of Washington. The registered enrollment target is 40,000 participants, above the 4,501-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (789% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06768814, a NA study of Opioid Use Disorder and Opioid Use, is actively recruiting participants, sponsored by University of Washington.

RECRUITING
Registry status
NA
Development phase
40,000 participants
Enrollment target
1
Study location

Study Summary

The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the intervention participants and two comparison groups will be utilized: eligible Seattle EMS patients who opt not to go to the SASC and King County residents, outside of Seattle, who meet the same eligibility criteria. A comparative interrupted time series analysis is planned to study the main effectiveness outcomes. Seattle Fire EMS will assess, refer, and arrange transport for participants to the SASC. The SASC will offer an array of services including post-overdose monitoring, utilization of buprenorphine and methadone for the treatment opioid use disorder and opioid withdrawal, linkage to ongoing care for OUD, and provision of harm reduction services and supplies. The length of stay in the SASC will be limited to less than 24 hours. A continuous process improvement (CPI) approach will monitor and refine the intervention. Characterization of the interventions will be based upon analysis of service utilization patterns over time along with interviews and surveys with stakeholders.

Primary Outcome

One of more opioid overdoses after enrollment

Interventions

  • BEHAVIORAL Sub-acute stabilization

Study Locations (1)

Washington

  • Downtown Emergency Service Center's Overdose Recovery and Care Access Centers - Seattle

Trial Details

FieldValue
Enrollment Target 40,000 participants
Start Date 2024-12-15
Est. Completion 2029-05-31
Phase NA
University of Washington

1,048 total trials

What NCT06768814 shows while recruiting

NCT06768814 is an interventional study that assigns participants to a tested intervention. Its 40,000 participants enrollment target places it among the larger protocols in the corpus, above the 4,501-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (789% higher).

The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Sub-acute stabilization is the first listed.

NCT06768814 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT06768814 about?

NCT06768814 is a clinical study titled "Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data". The study is a quasi-experimental investigation of a sub-acute stabilization center (SASC) for people who have had or are at risk for having an opioid overdose and have an encounter with Seattle Fire Department emergency medical services (EMS) in Seattle, WA. Those transported to the SASC are the in...

What is the current status of trial NCT06768814?

This trial is currently recruiting. It is a NA study. The enrollment target is 40,000 participants. The study started on 2024-12-15. Estimated completion is 2029-05-31.

What conditions does trial NCT06768814 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use.

What interventions are being tested in trial NCT06768814?

The interventions under investigation include: Sub-acute stabilization (BEHAVIORAL).

Who is sponsoring clinical trial NCT06768814?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06768814 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06768814's enrollment target sits among peer trials

40,000 3rd of 257 higher than 255 of 257 other Opioid Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01255748 · 40,000 participants

    Registry Study for Radiation Therapy Outcomes

  • NCT04994756 · 40,000 participants

    Stroke Thrombectomy and Aneurysm Registry

  • NCT07109427 · 40,000 participants · NA

    Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System

  • NCT05796505 · 37,122 participants · NA

    Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06768814, the US trial registry maintained by the National Library of Medicine. NCT06768814 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.